Browse Pet Safety Reports
8,562 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 8,562 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 8,562 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jul 7, 2018 | Dog | Retriever - Chesapeake Bay | Grapiprant | Lack of efficacy - NOS; Ulcerative dermatitis | Ongoing |
| Jul 5, 2018 | Dog | Terrier - Scottish | Afoxolaner | Epidermal collarette; Ulcerative dermatitis; Seborrhoea; Skin irritation | Outcome Unknown |
| Jul 3, 2018 | Dog | Doberman Pinscher | Oclacitinib Maleate | Crust; Dermatitis; Other abnormal test result NOS; INEFFECTIVE, ATOPY CONTROL... | Ongoing |
| Jul 3, 2018 | Dog | Collie (unspecified) | Afoxolaner | Self trauma; Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Jul 2, 2018 | Dog | Poodle - Standard | Genta/Momet/Clotrim Ear Oint | Ulcerative dermatitis; Hair change | Recovered/Normal |
| Jul 2, 2018 | Dog | Terrier - Yorkshire | Milbemycin Oxime; Praziquantel | Seizure NOS; Allergic dermatitis | Outcome Unknown |
| Jul 2, 2018 | Dog | Crossbred Canine/dog | Imidacloprid; Moxidectin | Application site dermatitis | Recovered/Normal |
| Jul 1, 2018 | Dog | Retriever - Labrador | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm; Hot spot (pyotraumatic dermatitis) | Ongoing |
| Jul 1, 2018 | Dog | Retriever - Labrador | Sarolaner | Hives (see also 'Skin'); Dermatitis | Outcome Unknown |
| Jul 1, 2018 | Dog | Terrier - Yorkshire | Spinosad; Milbemycin Oxime | Dermatitis; Vomiting; Diarrhoea; Not eating | Recovered/Normal |
| Jun 30, 2018 | Dog | Bulldog - French | Oclacitinib Maleate | Fungal skin infection NOS; Hot spot (pyotraumatic dermatitis); Death by eutha... | Euthanized |
| Jun 27, 2018 | Dog | Retriever - Labrador | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm; Dermatitis; Death by euthanasia | Euthanized |
| Jun 26, 2018 | Dog | Shepherd Dog (unspecified) | Clomipramine | Seizure NOS; Tremor of limb; Death; Muscle shaking; Eye disorder NOS (for pho... | Died |
| Jun 25, 2018 | Dog | Retriever - Labrador | Grapiprant | Dermatitis | Ongoing |
| Jun 25, 2018 | Dog | Terrier - Yorkshire | Fluralaner Chew Tablets | Seizure NOS; Collapse NOS (see also 'Cardio-vascular' and 'Neurological disor... | Ongoing |
| Jun 22, 2018 | Dog | Terrier (unspecified) | Afoxolaner | Itching; Erythema (for urticaria see Immune SOC); Hot spot (pyotraumatic derm... | Outcome Unknown |
| Jun 22, 2018 | Dog | Collie (unspecified) | Fluralaner Chew Tablets | Decreased appetite; Diarrhoea; Hot spot (pyotraumatic dermatitis); Hives (see... | Ongoing |
| Jun 21, 2018 | Dog | Shepherd Dog - Australian, ... | Selamectin | Dermatitis; Macular rash; Erythematous rash | Ongoing |
| Jun 21, 2018 | Dog | Crossbred Canine/dog, Shiba... | Fluralaner Chew Tablets | Crust; Erythematous rash; Moist dermatitis; Cardiac arrest | Outcome Unknown |
| Jun 20, 2018 | Dog | Bulldog | Fluralaner Chew Tablets | Hot spot (pyotraumatic dermatitis) | Ongoing |
| Jun 20, 2018 | Cat | Siamese | Semintra Telmisartan 4 Mg/Ml | Pruritus; Skin scab; Allergic dermatitis | Outcome Unknown |
| Jun 20, 2018 | Dog | Weimaraner | Moxidectin | Skin lesion NOS; Vomiting; Allergic dermatitis; Pruritus; Swelling NOS | Ongoing |
| Jun 19, 2018 | Cat | Domestic Shorthair | Insulin Injectable Vial | Dermatitis; Erythematous rash; Laceration | Ongoing |
| Jun 18, 2018 | Dog | Crossbred Canine/dog, Retri... | Fluralaner Chew Tablets | Ataxia; Elevated serum alkaline phosphatase (SAP); Hypothyroidism; Hyperadren... | Ongoing |
| Jun 17, 2018 | Dog | Shepherd Dog - German | Carprofen | Hot spot (pyotraumatic dermatitis) | Outcome Unknown |
| Jun 17, 2018 | Dog | Retriever - Labrador, Dog (... | Moxidectin | Hot spot (pyotraumatic dermatitis); Ocular discharge; Vomiting; Lethargy (see... | Ongoing |
| Jun 16, 2018 | Dog | Beagle | Grapiprant | Dermatitis; Vomiting | Ongoing |
| Jun 16, 2018 | Dog | Terrier - Yorkshire | Afoxolaner | Alopecia; Hyperpigmentation; Dermal thickening; Erythema (for urticaria see I... | Recovered/Normal |
| Jun 15, 2018 | Dog | Portuguese Water Dog | Oclacitinib Maleate | Urinary tract infection; Pododermatitis; Increased sensitivity to sound | Ongoing |
| Jun 15, 2018 | Dog | Crossbred Canine/dog, Pit B... | Fluralaner 13.64% Chew Tablets | Vomiting; Swollen vulva; Dermatitis; Lethargy (see also Central nervous syste... | Ongoing |
| Jun 14, 2018 | Dog | Shepherd Dog - Australian | Lotilaner | Itching; Decreased appetite; Hot spot (pyotraumatic dermatitis) | Ongoing |
| Jun 8, 2018 | Dog | Chihuahua | Selamectin | Moist dermatitis | Recovered/Normal |
| Jun 7, 2018 | Dog | Bullmastiff | Fluralaner Chew Tablets | Localised rash; Moist dermatitis; Discomfort NOS | Ongoing |
| Jun 6, 2018 | Dog | Terrier - Yorkshire, Poodle... | Trilostane | Elevated serum alkaline phosphatase (SAP); Elevated cholesterol (total); Anxi... | Ongoing |
| Jun 6, 2018 | Dog | Retriever - Golden | Afoxolaner | Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| Jun 5, 2018 | Dog | Pointing Dog - German Wire-... | Afoxolaner | Hot spot (pyotraumatic dermatitis); Skin irritation; Hair loss NOS | Outcome Unknown |
| Jun 4, 2018 | Dog | Retriever - Golden | Carprofen | Lethargy (see also Central nervous system depression in 'Neurological'); Skin... | Outcome Unknown |
| Jun 4, 2018 | Dog | Bulldog, Beagle | Oclacitinib Maleate | Dermatitis; INEFFECTIVE, ATOPY CONTROL | Ongoing |
| Jun 3, 2018 | Dog | Bulldog | Fluralaner Chew Tablets | Hot spot (pyotraumatic dermatitis) | Ongoing |
| Jun 2, 2018 | Dog | Great Pyrenees | Desoxycorticosterone Pivalate | Dermatitis; Electrolyte disorder; High sodium-potassium ratio (Na:K ratio); W... | Ongoing |
| Jun 1, 2018 | Dog | Collie (unspecified), Sheph... | Grapiprant | Pruritus; Hot spot (pyotraumatic dermatitis); Alopecia local | Ongoing |
| Jun 1, 2018 | Cat | Domestic Shorthair | Semintra Telmisartan 4 Mg/Ml | Skin scab; Allergic dermatitis | Recovered/Normal |
| Jun 1, 2018 | Dog | Pit Bull | Lotilaner | Seizure NOS; Allergic dermatitis; Death by euthanasia | Euthanized |
| Jun 1, 2018 | Dog | Pit Bull | Milbemycin Oxime; Praziquantel | Lack of efficacy (endoparasite) - heartworm; Allergic dermatitis | Outcome Unknown |
| May 31, 2018 | Horse | Quarter Horse | Methylprednisolone Acetate | Injection site inflammation; Application site weeping (see also 'skin'); Cont... | Ongoing |
| May 30, 2018 | Dog | Maltese, Shih Tzu | Rabacfosadine Succinate | Alopecia; Lethargy (see also Central nervous system depression in 'Neurologic... | Outcome Unknown |
| May 27, 2018 | Dog | Crossbred Canine/dog | Fluralaner Chew Tablets | Diarrhoea; Itching; Skin slough; Hot spot (pyotraumatic dermatitis) | Ongoing |
| May 24, 2018 | Cat | Domestic Shorthair | Praziquantel; Emodepside | Application site hair loss; Application site dermatitis | Outcome Unknown |
| May 22, 2018 | Dog | Shepherd Dog - German | Fluralaner Chew Tablets | Erythema (for urticaria see Immune SOC); Hot spot (pyotraumatic dermatitis) | Recovered/Normal |
| May 22, 2018 | Dog | Terrier - Yorkshire, Dog (u... | Maropitant Citrate | Lethargy (see also Central nervous system depression in 'Neurological'); Not ... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.